Online inquiry

IVTScrip™ pT7-VEE-mRNA-Anti-IGF, BI 836 Vector   (CAT#: GTVCR-WQ688MR)

This product GTVCR-WQ688MR is an effective transcription system suitable for a variety of research, including the in vitro translation, self-amplifying mRNA studies and protein expression. The system was driven by the T7 promoter to efficiently generate mRNA ecoding antibody which targeting IGF1&IGF2. The vector contains the self-replicating Venezuelan equine encephalitis (VEE) virus RNA replicon, which resulting the mRNA expression at a high level.

SPECIFIC INQUIRY

3' poly(A):
Inquiry
Specifications
Product type Vector
Promoter T7
Resistance Ampicillin
Species Homo sapiens
RefSeq NM_000618.5; NM_000612.6
Applications IVT; Self-amplifying mRNA (SAM) research; Gene therapy research
Format Solution
Concentration 1 µg/µl
Quantity 10 µg
Target Gene
Gene ID 3479; 3481
UniProt ID P05019; P01344
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ pT7-VEE-mRNA-Anti-IGF, BI 836 Vector (GTVCR-WQ688MR). Click the button above to contact us or submit your feedback about this product.

See other products
CAT Product Name Product Type CDs
GTVCR-WQ453MR IVTScrip™ pSP6-VEE-mRNA-Anti-TNFRSF10B, AMG 655 Vector Vector AMG 655
GTVCR-WQ2198MR IVTScrip™ pSP6-VEE-mRNA-Anti-APP, PF-04360365 Vector Vector PF-04360365
GTVCR-WQ2550MR IVTScrip™ pSP6-VEE-mRNA-Anti-CD38, TAK-079 Vector Vector TAK-079
GTVCR-WQ1551MR IVTScrip™ pT7-VEE-mRNA-Anti-CEACAM5, IMMU-130 Vector Vector IMMU-130
GTVCR-WQ821MR IVTScrip™ pSP6-VEE-mRNA-Anti-CD3E&MS4A1, BTCT4465A Vector Vector BTCT4465A
GTVCR-WQ1876MR IVTScrip™ pT7-VEE-mRNA-Anti-TNFRSF18, MEDI-1873 Vector Vector MEDI-1873
GTVCR-WQ1818MR IVTScrip™ pSP6-VEE-mRNA-Anti-FOLR1, M9346A Vector Vector M9346A
GTVCR-WQ2195MR IVTScrip™ pT7-VEE-mRNA-Anti-APP, PF-04360365 Vector Vector PF-04360365
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.